Oral solid dose formulation and process development
Optimising solid dosage forms for enhanced drug delivery and manufacturing efficiency .
Get to market faster with CPI
At CPI, we support the development, optimisation, and scale-up of oral solid dose (OSD) formulations to improve bioavailability, stability, and manufacturability.
Our expertise in tablet production, in-process monitoring, and advanced analytics helps you streamline development, support regulatory compliance, and scale efficiently. Whether optimising controlled-release profiles, improving solubility, or adopting continuous manufacturing technologies such as Continuous Direct Compression (CDC), we provide the infrastructure and insight to accelerate your path from formulation to commercialisation.
Oral solid dose formulation and process development
Optimising solid dosage forms for enhanced drug delivery and manufacturing efficiency .
Get to market faster with CPI
At CPI, we support the development, optimisation, and scale-up of oral solid dose (OSD) formulations to improve bioavailability, stability, and manufacturability.
Our expertise in tablet production, in-process monitoring, and advanced analytics helps you streamline development, support regulatory compliance, and scale efficiently. Whether optimising controlled-release profiles, improving solubility, or adopting continuous manufacturing technologies such as Continuous Direct Compression (CDC), we provide the infrastructure and insight to accelerate your path from formulation to commercialisation.
Oral solid dose formulation and process development
Optimising solid dosage forms for enhanced drug delivery and manufacturing efficiency .
Get to market faster with CPI
At CPI, we support the development, optimisation, and scale-up of oral solid dose (OSD) formulations to improve bioavailability, stability, and manufacturability.
Our expertise in tablet production, in-process monitoring, and advanced analytics helps you streamline development, support regulatory compliance, and scale efficiently. Whether optimising controlled-release profiles, improving solubility, or adopting continuous manufacturing technologies such as Continuous Direct Compression (CDC), we provide the infrastructure and insight to accelerate your path from formulation to commercialisation.
What we offer
Whether you need technical consultancy, lab-based development, process optimisation or digitalisation support, our tailored approach ensures you have the right expertise at every stage.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Characterisation of raw material properties
Optimise raw material selection and processing with our analytical capabilities:
Particle size distribution (PSD) and morphology analysis.
Flowability, compressibility, and moisture content assessment.
Crystallinity and polymorphism studies.
Physical and chemical stability testing.
Chemical purity assessments.
These analyses underpin robust formulation design and consistent product performance.
Powder blend characterisation and optimisation
Ensure blend uniformity and formulation stability with our support in:
Blend and content uniformity testing.
Granulation and dry mixing optimisation.
Shear sensitivity and powder flow studies.
Moisture sorption/ desorption analysis.
Development for scale-up and semi-continuous/continuous manufacturing.
These insights enhance efficiency and product quality across the development lifecycle.
Tablet and capsule development, manufacture, and characterisation
We help you optimise tablet and capsule manufacture for performance and scale:
Formulation development for dissolution, bioavailability, and flowability.
Tablet hardness, friability, and disintegration testing.
Dissolution and release kinetics studies.
Compression and compaction profile optimisation.
Coating technologies for taste masking or modified release.
Our support ensures robust, scalable, and patient-friendly solid dose products.
Process analytical technology (PAT) for in-line monitoring and control
Develop real-time control strategies with advanced process monitoring tools:
CDC to reduce complexity and improve efficiency.
NIR and Raman spectroscopy for in-line monitoring — including blend uniformity prior to tableting.
Granulation and drying endpoint determination.
Process control strategies for continuous manufacturing.
Data analytics and digital modelling for process optimisation.
QbD implementation to support regulatory readiness.
Sustainable manufacturing
Reduce environmental impact while boosting efficiency:
Implement CDC to eliminate energy-intensive steps like granulation.
Reduce water, material use and waste through first-intent CDC.
Conduct Life Cycle Analysis to target Scope 1–3 emissions reductions.
Use digital twins to predict tablet quality from material and process settings.
Automate processes for continuous direct manufacturing.
We help you reduce variability, lower emissions, and drive sustainable innovation.
What we offer
Whether you need technical consultancy, lab-based development, process optimisation or digitalisation support, our tailored approach ensures you have the right expertise at every stage.
Characterisation of raw material properties
Optimise raw material selection and processing with our analytical capabilities:
Particle size distribution (PSD) and morphology analysis.
Flowability, compressibility, and moisture content assessment.
Crystallinity and polymorphism studies.
Physical and chemical stability testing.
Chemical purity assessments.
These analyses underpin robust formulation design and consistent product performance.
Powder blend characterisation and optimisation
Ensure blend uniformity and formulation stability with our support in:
Blend and content uniformity testing.
Granulation and dry mixing optimisation.
Shear sensitivity and powder flow studies.
Moisture sorption/ desorption analysis.
Development for scale-up and semi-continuous/continuous manufacturing.
These insights enhance efficiency and product quality across the development lifecycle.
Tablet and capsule development, manufacture, and characterisation
We help you optimise tablet and capsule manufacture for performance and scale:
Formulation development for dissolution, bioavailability, and flowability.
Tablet hardness, friability, and disintegration testing.
Dissolution and release kinetics studies.
Compression and compaction profile optimisation.
Coating technologies for taste masking or modified release.
Our support ensures robust, scalable, and patient-friendly solid dose products.
Process analytical technology (PAT) for in-line monitoring and control
Develop real-time control strategies with advanced process monitoring tools:
CDC to reduce complexity and improve efficiency.
NIR and Raman spectroscopy for in-line monitoring — including blend uniformity prior to tableting.
Granulation and drying endpoint determination.
Process control strategies for continuous manufacturing.
Data analytics and digital modelling for process optimisation.
QbD implementation to support regulatory readiness.
Sustainable manufacturing
Reduce environmental impact while boosting efficiency:
Implement CDC to eliminate energy-intensive steps like granulation.
Reduce water, material use and waste through first-intent CDC.
Conduct Life Cycle Analysis to target Scope 1–3 emissions reductions.
Use digital twins to predict tablet quality from material and process settings.
Automate processes for continuous direct manufacturing.
We help you reduce variability, lower emissions, and drive sustainable innovation.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
What we offer
Whether you need technical consultancy, lab-based development, process optimisation or digitalisation support, our tailored approach ensures you have the right expertise at every stage.
Characterisation of raw material properties
Optimise raw material selection and processing with our analytical capabilities:
Particle size distribution (PSD) and morphology analysis.
Flowability, compressibility, and moisture content assessment.
Crystallinity and polymorphism studies.
Physical and chemical stability testing.
Chemical purity assessments.
These analyses underpin robust formulation design and consistent product performance.
Powder blend characterisation and optimisation
Ensure blend uniformity and formulation stability with our support in:
Blend and content uniformity testing.
Granulation and dry mixing optimisation.
Shear sensitivity and powder flow studies.
Moisture sorption/ desorption analysis.
Development for scale-up and semi-continuous/continuous manufacturing.
These insights enhance efficiency and product quality across the development lifecycle.
Tablet and capsule development, manufacture, and characterisation
We help you optimise tablet and capsule manufacture for performance and scale:
Formulation development for dissolution, bioavailability, and flowability.
Tablet hardness, friability, and disintegration testing.
Dissolution and release kinetics studies.
Compression and compaction profile optimisation.
Coating technologies for taste masking or modified release.
Our support ensures robust, scalable, and patient-friendly solid dose products.
Process analytical technology (PAT) for in-line monitoring and control
Develop real-time control strategies with advanced process monitoring tools:
CDC to reduce complexity and improve efficiency.
NIR and Raman spectroscopy for in-line monitoring — including blend uniformity prior to tableting.
Granulation and drying endpoint determination.
Process control strategies for continuous manufacturing.
Data analytics and digital modelling for process optimisation.
QbD implementation to support regulatory readiness.
Sustainable manufacturing
Reduce environmental impact while boosting efficiency:
Implement CDC to eliminate energy-intensive steps like granulation.
Reduce water, material use and waste through first-intent CDC.
Conduct Life Cycle Analysis to target Scope 1–3 emissions reductions.
Use digital twins to predict tablet quality from material and process settings.
Automate processes for continuous direct manufacturing.
We help you reduce variability, lower emissions, and drive sustainable innovation.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
What we offer
Whether you need technical consultancy, lab-based development, process optimisation or digitalisation support, our tailored approach ensures you have the right expertise at every stage.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Characterisation of raw material properties
Optimise raw material selection and processing with our analytical capabilities:
Particle size distribution (PSD) and morphology analysis.
Flowability, compressibility, and moisture content assessment.
Crystallinity and polymorphism studies.
Physical and chemical stability testing.
Chemical purity assessments.
These analyses underpin robust formulation design and consistent product performance.
Powder blend characterisation and optimisation
Ensure blend uniformity and formulation stability with our support in:
Blend and content uniformity testing.
Granulation and dry mixing optimisation.
Shear sensitivity and powder flow studies.
Moisture sorption/ desorption analysis.
Development for scale-up and semi-continuous/continuous manufacturing.
These insights enhance efficiency and product quality across the development lifecycle.
Tablet and capsule development, manufacture, and characterisation
We help you optimise tablet and capsule manufacture for performance and scale:
Formulation development for dissolution, bioavailability, and flowability.
Tablet hardness, friability, and disintegration testing.
Dissolution and release kinetics studies.
Compression and compaction profile optimisation.
Coating technologies for taste masking or modified release.
Our support ensures robust, scalable, and patient-friendly solid dose products.
Process analytical technology (PAT) for in-line monitoring and control
Develop real-time control strategies with advanced process monitoring tools:
CDC to reduce complexity and improve efficiency.
NIR and Raman spectroscopy for in-line monitoring — including blend uniformity prior to tableting.
Granulation and drying endpoint determination.
Process control strategies for continuous manufacturing.
Data analytics and digital modelling for process optimisation.
QbD implementation to support regulatory readiness.
Sustainable manufacturing
Reduce environmental impact while boosting efficiency:
Implement CDC to eliminate energy-intensive steps like granulation.
Reduce water, material use and waste through first-intent CDC.
Conduct Life Cycle Analysis to target Scope 1–3 emissions reductions.
Use digital twins to predict tablet quality from material and process settings.
Automate processes for continuous direct manufacturing.
We help you reduce variability, lower emissions, and drive sustainable innovation.
Oral solid dose formulation and process development
applications
We enable innovation across a wide range of oral solid dose products.
In-line process analytical technology (PAT).
Tablet and capsule formulation.
Controlled-release drug delivery.
Powder blending and granulation.
Continuous manufacturing.
Additive manufacturing.
Digital and automation.
How we support you
From discovery to commercialisation, we enable sustainable, scalable, and profitable pharmaceutical innovations.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Demonstrate the benefits of your oral solid dose formulation
Accelerate development and showcase product potential through:
Rapid, cost-effective formulation optimisation.
Validation in real-world, industry-relevant environments.
Improved bioavailability, stability, and patient outcomes.
Prove manufacturability and scalability
Build confidence in your path to market with:
Feasibility assessments for early manufacturability.
Scalable process development tailored for clinical and commercial readiness.
Integration of continuous technologies to streamline scale-up.
Assess and demonstrate commercial viability
We generate the technical and economic evidence needed to secure investment and partnerships:
Commercial feasibility studies for oral solid dose formulations.
Streamline regulatory compliance
De-risk your regulatory journey with support from experts in:
GMP-aligned development and manufacturing facilities.
Quality documentation aligned with international standards.
Secure strategic partnerships
As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare, and academia. We help you to:
Access world-class solid dose formulation experts and manufacturing partners.
Build robust supply chains for tablet and capsule production.
Collaborate on industry-wide solid dose innovation challenges.
How we support you
From discovery to commercialisation, we enable sustainable, scalable, and profitable pharmaceutical innovations.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
Demonstrate the benefits of your oral solid dose formulation
Accelerate development and showcase product potential through:
Rapid, cost-effective formulation optimisation.
Validation in real-world, industry-relevant environments.
Improved bioavailability, stability, and patient outcomes.
Prove manufacturability and scalability
Build confidence in your path to market with:
Feasibility assessments for early manufacturability.
Scalable process development tailored for clinical and commercial readiness.
Integration of continuous technologies to streamline scale-up.
Assess and demonstrate commercial viability
We generate the technical and economic evidence needed to secure investment and partnerships:
Commercial feasibility studies for oral solid dose formulations.
Streamline regulatory compliance
De-risk your regulatory journey with support from experts in:
GMP-aligned development and manufacturing facilities.
Quality documentation aligned with international standards.
Secure strategic partnerships
As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare, and academia. We help you to:
Access world-class solid dose formulation experts and manufacturing partners.
Build robust supply chains for tablet and capsule production.
Collaborate on industry-wide solid dose innovation challenges.
How we support you
From discovery to commercialisation, we enable sustainable, scalable, and profitable pharmaceutical innovations.
Demonstrate the benefits of your oral solid dose formulation
Accelerate development and showcase product potential through:
Rapid, cost-effective formulation optimisation.
Validation in real-world, industry-relevant environments.
Improved bioavailability, stability, and patient outcomes.
Prove manufacturability and scalability
Build confidence in your path to market with:
Feasibility assessments for early manufacturability.
Scalable process development tailored for clinical and commercial readiness.
Integration of continuous technologies to streamline scale-up.
Assess and demonstrate commercial viability
We generate the technical and economic evidence needed to secure investment and partnerships:
Commercial feasibility studies for oral solid dose formulations.
Streamline regulatory compliance
De-risk your regulatory journey with support from experts in:
GMP-aligned development and manufacturing facilities.
Quality documentation aligned with international standards.
Secure strategic partnerships
As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare, and academia. We help you to:
Access world-class solid dose formulation experts and manufacturing partners.
Build robust supply chains for tablet and capsule production.
Collaborate on industry-wide solid dose innovation challenges.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
How we support you
From discovery to commercialisation, we enable sustainable, scalable, and profitable pharmaceutical innovations.
Demonstrate the benefits of your oral solid dose formulation
Accelerate development and showcase product potential through:
Rapid, cost-effective formulation optimisation.
Validation in real-world, industry-relevant environments.
Improved bioavailability, stability, and patient outcomes.
Prove manufacturability and scalability
Build confidence in your path to market with:
Feasibility assessments for early manufacturability.
Scalable process development tailored for clinical and commercial readiness.
Integration of continuous technologies to streamline scale-up.
Assess and demonstrate commercial viability
We generate the technical and economic evidence needed to secure investment and partnerships:
Commercial feasibility studies for oral solid dose formulations.
Streamline regulatory compliance
De-risk your regulatory journey with support from experts in:
GMP-aligned development and manufacturing facilities.
Quality documentation aligned with international standards.
Secure strategic partnerships
As a trusted UK Government partner, we have built a broad network across global leaders, emerging companies, large corporates, healthcare, and academia. We help you to:
Access world-class solid dose formulation experts and manufacturing partners.
Build robust supply chains for tablet and capsule production.
Collaborate on industry-wide solid dose innovation challenges.
Can't find what you're looking for?
With over 500 experts we are here to help.
500+
We are over 500 world-class innovation experts, scientists and engineers.
We are over 500 world-class innovation experts, scientists and engineers.
We are over 500 world-class innovation experts, scientists and engineers.
£3 billion of private investment unlocked
R&D projects delivered
Years of experience
Business collaborations
m² of facilities
Over £220m of innovation assets
£3 billion of private investment unlocked
R&D projects delivered
Years of experience
Business collaborations
m² of facilities
Over £220m of innovation assets
£3 billion of private investment unlocked
R&D projects delivered
Years of experience
Business collaborations
m² of facilities
Over £220m of innovation assets
Trusted by leading organisations
We chose Teesside as a preferred location due to the commercial attractiveness, technical skills and research and development expertise in the area.
Alan Shaw
CEO
,
Calysta
Why choose CPI?
Work with us to defer capital and workforce investments until your product or process is proven at scale.
Formulation expertise
Proven success in solid dose development and optimisation.
Industry-leading infrastructure
Supporting GMP production scale OSD manufacturing.
Collaborative approach
We connect you with industry partners, funding opportunities, and regulatory agencies to de-risk your journey.
End-to-end support
From early-stage formulation to commercial production.
Sustainable innovation
We help reduce waste, emissions, and energy use through first-intent CDC, automation, and life cycle analysis.n
Advanced process analytics
We use real-time monitoring, digital twins, and data-driven models to optimise tablet quality and manufacturing efficiency.
Get in touch
Let's innovate together
At CPI, we understand that every innovation, manufacturing process, and application is unique. Our flexible engagement model builds custom projects around your goals.
Oral solid dose formulation and process development
Business Development
Get in touch
Let's innovate together
At CPI, we understand that every innovation, manufacturing process, and application is unique. Our flexible engagement model builds custom projects around your goals.
Oral solid dose formulation and process development
Business Development
Get in touch
Let's innovate together
At CPI, we understand that every innovation, manufacturing process, and application is unique. Our flexible engagement model builds custom projects around your goals.
Oral solid dose formulation and process development
Business Development
